Stay updated on ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.6.4 was added to the history list, replacing Revision: v3.6.3, indicating a small update to the page's UI/backend.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.6.3 was added in place of Revision: v3.6.2 in the page footer, indicating a deployment update to the site's software. The update does not change visible content.SummaryDifference0.0%

- Check39 days agoChange DetectedA new revision entry v3.6.2 was added to the record history, and the previous v3.6.0 entry was removed. This updates the historical record to reflect the latest revision state.SummaryDifference0.0%

- Check54 days agoChange DetectedThe study history now reflects that recruitment has ended, and the version history shows a new revision entry (v3.6.0) with the previous revision (v3.5.5) removed.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page footer revision label was updated from v3.5.4 to v3.5.5, indicating a newer version of the page rendering.SummaryDifference0.0%

- Check82 days agoChange DetectedThe study's revision history now shows Revision: v3.5.4 replacing Revision: v3.5.3, indicating an administrative update to the record. This change does not alter the study data, eligibility, or results.SummaryDifference0.0%

Stay in the know with updates to ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page.